Baron Funds, an investment management company, released its “Baron Health Care Fund” second-quarter 2025 investor letter. A ...

Easy at-home tests for colon cancer, including FIT and Cologuard, offer alternatives to traditional colonoscopies for early ...

The Cologuard Plus test is being offered as an in-network service to eligible Humana Medicare Advantage members.

Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced an expanded ...

Cologuard is easy for patients to use and easy for doctors to interpret the results, said Dr. Casey Allen, a surgical oncologist at Allegheny Health Network in Pennsylvania.

The Cologuard test is not a replacement for colonoscopy in high risk patients. Cologuard performance in adults ages 45-49 is estimated based on a large clinical study of patients 50 and older.

The Cologuard can say that you have an abnormality when a colonoscopy would indicate normal. For 45% of people with a positive Cologuard test, no abnormalities will be found upon colonoscopy.

In addition, because more people using Cologuard end up with CRC, the 10-year costs of CRC (inclusive of screening) are anywhere from $1,000 to $1,400 higher per Cologuard user [2].

Cologuard measures DNA methylation in two genes: NDRG4 and BMP3. Abnormal methylation of NDRG4 and BMP3, considered tumor suppressors, has been linked to colorectal tumors.

Unlock URL Order Reprints Gift this Article An image from Cologuard's television ad By Teddy Nykiel – Reporter, Milwaukee Business Journal Mar 2, 2022 Updated Mar 3, 2022 10:26am CST ...

Cologuard’s greatest benefit, Roth said, is that it could encourage more people to have a colonoscopy, which remains the gold standard for diagnosing and treating colon cancer.

Outside of those patients, Cologuard will own its addressable market and be rapidly adopted by physicians. Eventual penetration into the 70% range of this market is reasonable, and even at $300 ...